Welcome to our dedicated page for LJAQ news (Ticker: LJAQ), a resource for investors and traders seeking the latest updates and insights on LJAQ stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect LJAQ's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of LJAQ's position in the market.
LightJump Acquisition Corporation (NASDAQ: LJAQ) received a notice from Nasdaq on May 28, 2021, due to the failure to timely file its Quarterly Report on Form 10-Q for Q1 2021, violating Nasdaq Listing Rule 5250(c)(1). While this notice does not immediately impact the trading of LJAQ's securities, the company must file the required form within 60 days or submit a compliance plan. The filing delay may be influenced by ongoing evaluations related to the accounting treatment of warrants based on recent SEC guidance. Failure to regain compliance may lead to delisting.
FAQ
What is the market cap of LJAQ (LJAQ)?
